Nitric oxide and endothelin in the development of cardiac allograft vasculopathy. Potential targets for therapeutic interventions
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kaye, 1993, The Registry of the International Society for Heart Lung Transplantation: Tenth official report, J Heart Lung Transplant, 12, 541
Alderman, 1989, Angiographic implications of cardiac transplantation, Am J Cardiol, 64, 16E, 10.1016/0002-9149(89)90729-7
Weis, 1997, Cardiac allograft vasculopathy: A review, Circulation, 96, 2069, 10.1161/01.CIR.96.6.2069
Gao, 1988, Accelerated coronary vascular disease in heart transplant patients: coronary arteriographic findings, J Am Coll Cardiol, 12, 334, 10.1016/0735-1097(88)90402-0
Duquesnoy, 1995, Immunopathology of cardiac transplant rejection, Curr Opin Cardiol, 10, 193, 10.1097/00001573-199503000-00014
Clausell, 1997, Histological and immunohistochemical characteristics of eccentric coronary artery lesions retrieved by atherectomy from cardiac transplant recipients, Cardiovasc Pathol, 6, 23, 10.1016/S1054-8807(96)00069-5
Russel, 1995, Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis, Circulation, 92, 457, 10.1161/01.CIR.92.3.457
Rabinovitch, 1995, Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches, J Heart Lung Transplant, 114, 116
Treasure, 1995, Relevance of vascular biology to the ischemic syndromes of coronary atherosclerosis, Cardiovasc Drugs Ther, 9, 13, 10.1007/BF00878568
Ross, 1993, The pathogenesis of atherosclerosis: A perspective of the 1990s, Nature, 362, 801, 10.1038/362801a0
Davis, 1996, Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant, Circulation, 93, 457, 10.1161/01.CIR.93.3.457
Rubanyi, 1993, The role of endothelium in cardiovascular homeostasis and diseases, J Cardiovasc Pharmacol, 22, 1, 10.1097/00005344-199322004-00002
Radomski, 1995, Nitric oxide—Biological mediator, modulator and factor of injury: its role in the pathogenesis of atherosclerosis, Atherosclerosis, 118, 69, 10.1016/0021-9150(95)90075-6
Lerman, 1995, Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans, Circulation, 92, 2426, 10.1161/01.CIR.92.9.2426
Marletta, 1988, Macrophage oxidation of l-arginine to nitrite/and nitrate: nitric oxide is an intermediate, Biochemistry, 27, 8706, 10.1021/bi00424a003
Yui, 1991, Calmodulin-independent nitric oxide synthase from rat polymorphonuclear neutrophils, J Biol Chem, 266, 3369, 10.1016/S0021-9258(19)67800-2
Drapier, 1988, Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in l-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells, J Immunol, 140, 2829, 10.4049/jimmunol.140.8.2829
Stuehr, 1987, Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines or interferon-γ, J Immunol, 139, 518, 10.4049/jimmunol.139.2.518
Ding, 1988, Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages, J Immunol, 141, 2407, 10.4049/jimmunol.141.7.2407
Xie, 1992, Cloning and characterization of inducible nitric oxide synthase from mouse macrophage, Science, 256, 225, 10.1126/science.1373522
Kelm, 1990, Control of coronary vascular tone by nitric oxide, Circ Res, 66, 1561, 10.1161/01.RES.66.6.1561
Nathan, 1994, Nitric oxide synthase: roles, toll, controls, Cell, 78, 915, 10.1016/0092-8674(94)90266-6
Lincoln, 1989, Cyclic GMP and mechanisms of vasodilation, Pharmacol Ther, 41, 479, 10.1016/0163-7258(89)90127-7
Lowenstein, 1994, Nitric oxide: A physiological messenger, Ann Intern Med, 120, 227, 10.7326/0003-4819-120-3-199402010-00009
Rees, 1989, Role of endothelium-derived nitric oxide in the regulation of blood pressure, Proc Natl Acad Sci USA, 86, 3375, 10.1073/pnas.86.9.3375
Palmer, 1993, The discovery of nitric oxide in the vessel wall: a unifying concept in the pathogenesis of sepsis, Arch Surg, 128, 396, 10.1001/archsurg.1993.01420160034004
Gardiner, 1990, Control of regional blood flow by endothelium-derived nitric oxide, Hypertension, 15, 486, 10.1161/01.HYP.15.5.486
Rand, 1992, Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission, Clin Exp Pharmacol Physiol, 19, 147, 10.1111/j.1440-1681.1992.tb00433.x
Lee, 1990, Functional analysis of the endothelin-1 gene promoter: evidence for an endothelial cell-specific cis-acting sequence, J Biol Chem, 265, 10446, 10.1016/S0021-9258(18)86967-8
Nakamura, 1990, Immunocytochemical localization of endothelin in cultured bovine endothelial cells, Histochemistry, 94, 475, 10.1007/BF00272609
Shinmi, 1989, Endothelin-3 is a novel neuropeptide: isolation and sequence determination of endothelin-1 and endothelin-3 in porcine brain, Biochem Biophys Res Commun, 164, 587, 10.1016/0006-291X(89)91760-9
Arai, 1990, Cloning and expression of a cDNA encoding an endothelin receptor, Nature, 348, 730, 10.1038/348730a0
Simonson, 1990, Cellular signaling by peptides of the endothelin gene family, FASEB J, 4, 2989, 10.1096/fasebj.4.12.2168326
Goligorsky, 1994, Termination of endothelin signaling: role of nitric oxide, J Cell Physiol, 158, 485, 10.1002/jcp.1041580313
Simonson, 1993, Protein kinase C and protein tyrosine kinase activity contribute to mitogenic signaling by endothelin-1: cross-talk between G protein-coupled receptors and PP60C-src, J Biol Chem, 268, 9347, 10.1016/S0021-9258(18)98357-2
Sakurai, 1990, Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor, Nature, 348, 732, 10.1038/348732a0
Aramori, 1992, Coupling of two endothelin receptor subtypes to differing signal transduction in transfected Chinese hamster ovary cells, J Biol Chem, 267, 12468, 10.1016/S0021-9258(18)42300-9
Koh, 1990, Endothelin stimulates Na+/H+ exchange in vascular smooth muscle cells, Biochem Int, 20, 375
Hirata, 1993, Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells, J Clin Invest, 91, 1367, 10.1172/JCI116338
Filep, 1991, Antiaggregatory and hypotensive effects of endothelin-1 in beagle dogs: role for prostacyclin, J Cardiovasc Pharmacol, 17, S216, 10.1097/00005344-199100177-00062
Cozza, 1992, Endothelin-1 potentiation of angiotension II stimulation of aldosterone production, Am J Physiol, 262, R85
Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial, New Engl J Med, 327, 669, 10.1056/NEJM199209033271001
Boulanger, 1990, Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide, J Clin Invest, 85, 587, 10.1172/JCI114477
Prins, 1994, Prostaglandin E2 and prostacyclin inhibit the production and secretion of endothelin from cultured endothelial cells, J Biol Chem, 269, 11938, 10.1016/S0021-9258(17)32663-7
Lloyd-Jones, 1996, The vascular biology of nitric oxide and its role in atherosclerosis, Annu Rev Med, 47, 365, 10.1146/annurev.med.47.1.365
Tanner, 1993, Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: Alterations in hypercholesterolemia and atherosclerosis, Semin Thromb Hemost, 19, 167, 10.1055/s-2007-994021
Lukaszyk, 1994, Nitric oxide synthase inhibition and platelet function, Thromb Res, 75, 667, 10.1016/0049-3848(94)90180-5
Chester, 1990, Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries, Lancet, 336, 897, 10.1016/0140-6736(90)92269-N
Pinsky, 1994, Cardiac preservation is enhanced in a heterotopic rat transplant model by supplementing the nitric oxide pathway, J Clin Invest, 93, 2291, 10.1172/JCI117230
Drexler, 1994, Effect of l-arginine on coronary endothelial function in cardiac transplant recipients, Circulation, 89, 1615, 10.1161/01.CIR.89.4.1615
Loscalzo, 1995, Nitric oxide and its role in the cardiovascular system, Prog Cardiovasc Dis, 38, 87, 10.1016/S0033-0620(05)80001-5
Haller, 1997, Endothelial function: General considerations, Drugs, 53, 1, 10.2165/00003495-199700531-00003
Jang, 1994, Cell adhesion molecules in coronary artery disease, J Am Coll Cardiol, 24, 1591, 10.1016/0735-1097(94)90162-7
Lüscher, 1988, Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts, New Engl J Med, 319, 462, 10.1056/NEJM198808253190802
Mellion, 1981, Evidence for the inhibitory role of guanosine 3′,5′-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators, Blood, 57, 946, 10.1182/blood.V57.5.946.946
Golino, 1992, Endothelium-derived relaxing factor modulates platelet aggregation in an in vivo model of recurrent platelet activation, Circ Res, 71, 1447, 10.1161/01.RES.71.6.1447
Yao, 1992, Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries, Circulation, 86, 1302, 10.1161/01.CIR.86.4.1302
Houston, 1994, Influence of endothelium-derived relaxing factor on platelet function and hemostasis in vivo, Thromb Res, 74, 25, 10.1016/0049-3848(94)90033-7
Radomski, 1990, An l-arginine/nitric oxide pathway present in human platelets regulates aggregation, Proc Natl Acad Sci USA, 87, 5193, 10.1073/pnas.87.13.5193
Lelchuk, 1992, Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells, J Pharmacol Exp Ther, 262, 1220
Alheid, 1989, Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cyclic AMP and cyclic GMP, Eur J Pharmacol, 164, 103, 10.1016/0014-2999(89)90236-7
Houston, 1990, Inhibition of intravascular platelet aggregation by endothelium-derived relaxing factor: reversal by red blood cells, Blood, 76, 953, 10.1182/blood.V76.5.953.953
Broekman, 1991, Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism, Blood, 78, 1033, 10.1182/blood.V78.4.1033.1033
Radomski, 1987, Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets, Br J Pharmacol, 92, 181, 10.1111/j.1476-5381.1987.tb11310.x
Gorman, 1977, Modulation of human platelet adenylate cyclase by prostacyclin, Prostaglandins, 13, 377, 10.1016/0090-6980(77)90018-1
Stamler, 1989, Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin E1, and nitroglycerin, Circ Res, 65, 796, 10.1161/01.RES.65.3.796
Adams, 1995, Oral l-arginine inhibits platelet aggregating but does not enhance endothelium-dependent dilation in healthy young men, J Am Coll Cardiol, 26, 1054, 10.1016/0735-1097(95)00257-9
Bode-Böger, 1994, l-Arginine infusion decreases peripheral arterial resistance and inhibits platelet aggregation in healthy subjects, Clin Sci, 87, 303, 10.1042/cs0870303
Bath, 1993, The effect of nitric oxide-donating vasodilators on monocytes chemotaxis and intracellular cGMP concentrations in vitro, Eur J Clin Pharmacol, 45, 53, 10.1007/BF00315350
Lefer, 1993, Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium, Arterioscler Thromb, 13, 771, 10.1161/01.ATV.13.6.771
Vanhoutte, 1989, Endothelium-derived relaxing factor and coronary vasospasm, Circulation, 80, 1, 10.1161/01.CIR.80.1.1
Kubes, 1991, Nitric oxide: an endogenous modulator of leukocyte adhesion, Proc Natl Acad Sci USA, 88, 4651, 10.1073/pnas.88.11.4651
Clancy, 1992, Nitric oxide, an endothelial derived relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH-oxidase, J Clin Invest, 90, 1116, 10.1172/JCI115929
Kubes, 1991, Nitric oxide: an endogenous modulator of leukocyte adhesion, Proc Natl Acad Sci USA, 88, 4651, 10.1073/pnas.88.11.4651
Ross, 1993, The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, 362, 801, 10.1038/362801a0
Dinerman, 1993, Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease, Circ Res, 73, 217, 10.1161/01.RES.73.2.217
Garg, 1989, Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat aortic smooth muscle cells, J Clin Invest, 83, 1774, 10.1172/JCI114081
Garg, 1991, Nitric oxide and 8-bromo-cyclic-GMP inhibit the mitogenic effect of both competence and progression factors in cultured rat aortic smooth muscle cells, FASEB J, 5, A1608
Garg, 1990, Nitric oxide generating vasodilators inhibit mitogenesis and proliferation of BALB/C3T3 fibroblasts by a cyclic GMP-independent mechanism, Biochem Biophys Res Commun, 171, 474, 10.1016/0006-291X(90)91417-Q
Taguchi, 1993, l-Arginine inhibits neointima formation following balloon injury, Life Sci, 53, 387, 10.1016/0024-3205(93)90167-2
Von der Leyen, 1994, Overexpression of constitutive, endothelial-type nitric oxide synthase as an in vivo gene transfer approach to prevent neointima formation after vascular injury (Abstr), Clin Res, 42, 180A
Scott-Burden, 1993, The endothelium as a regulator of vascular smooth muscle proliferation, Circulation, 87, V51
Geng, 1992, Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells, Circ Res, 71, 1268, 10.1161/01.RES.71.5.1268
Hogg, 1993, Inhibition of low-density lipoprotein oxidation by nitric oxide: potential role in atherogenesis, FEBS, 334, 170, 10.1016/0014-5793(93)81706-6
Chang, 1994, Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide: dependence on pH and oxygen, Arterioscler Thromb, 14, 1808, 10.1161/01.ATV.14.11.1808
Creager, 1990, Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans, J Clin Invest, 86, 228, 10.1172/JCI114688
Förstermann, 1988, Response of human coronary arteries to aggregating platelets: importance of endothelium-derived relaxing factor and prostanoids, Circ Res, 63, 306, 10.1161/01.RES.63.2.306
Johnstone, 1993, Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus, Circulation, 88, 2510, 10.1161/01.CIR.88.6.2510
Quyyumi, 1997, Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P, Circulation, 95, 104, 10.1161/01.CIR.95.1.104
Shi, 1997, Hypercholsterolemia exacerbates transplant atherosclerosis via increased neointimal smooth muscle cell accumulation, Circulation, 96, 2722, 10.1161/01.CIR.96.8.2722
Shimokawa, 1989, Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries, J Am Coll Cardiol, 13, 1402, 10.1016/0735-1097(89)90318-5
Drexler, 1991, Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by l-arginine, Lancet, 338, 1546, 10.1016/0140-6736(91)92372-9
Guerra Jr, 1989, Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis: implications for altered autocrine and paracrine functions of EDRF, Blood Vessels, 26, 300
Girerd, 1990, l-Arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits, Circ Res, 67, 1301, 10.1161/01.RES.67.6.1301
Cooke, 1991, Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta, Circulation, 83, 1057, 10.1161/01.CIR.83.3.1057
Habib, 1986, Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110, Circ Res, 58, 305, 10.1161/01.RES.58.2.305
Cayatte, 1994, Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits, Arterioscler Thromb, 14, 753, 10.1161/01.ATV.14.5.753
Förstermann, 1988, Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries, Circ Res, 62, 185, 10.1161/01.RES.62.2.185
Vita, 1990, Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease, Circulation, 81, 491, 10.1161/01.CIR.81.2.491
Otsuji, 1995, Attenuation of acetylcholine-induced vasoconstriction by l-arginine is related to the progression of atherosclerosis, Am Heart J, 129, 1094, 10.1016/0002-8703(95)90388-7
Arcaro, 1995, Non-invasive detection on early endothelial dysfunction in hypercholesterolemic subjects, Atherosclerosis, 114, 247, 10.1016/0021-9150(94)05489-6
Lewis, 1996, Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle, Circulation, 93, 720, 10.1161/01.CIR.93.4.720
Worrall, 1996, Inhibition of inducible nitric oxide synthase prevents myocardial and systemic vascular barrier dysfunction during early cardiac allograft rejection, Circ Res, 78, 769, 10.1161/01.RES.78.5.769
Esaki, 1997, Expression of inducible nitric oxide synthase in T-lymphocytes and macrophages of cholesterol fed rabbits, Atherosclerosis, 128, 39, 10.1016/S0021-9150(96)05976-X
Villa, 1994, Peroxynitrite induces both vasodilation and impaired vascular relaxation in the isolated perfused rat heart, Proc Natl Acad Sci USA, 91, 12383, 10.1073/pnas.91.26.12383
Beckmen, 1990, Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide, Proc Natl Acad Sci USA, 87, 1620, 10.1073/pnas.87.4.1620
Matthys, 1996, Dual effects of oxidized low-density lipoprotein on immune stimulated nitric oxide and prostaglandin release in macrophages, Eur J Pharmacol, 298, 97, 10.1016/0014-2999(95)00810-1
Yang, 1996, Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis, J Nutr, 126, 1072, 10.1093/jn/126.suppl_4.1072S
De Belder, 1995, Megacariocytes from patients with coronary atherosclerosis express the inducible nitric oxide synthase, Arterioscler Thromb Vasc Biol, 15, 637, 10.1161/01.ATV.15.5.637
Adeagbo, 1993, Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoreceptor-mediated response in rat aorta, Br J Pharmacol, 109, 495, 10.1111/j.1476-5381.1993.tb13597.x
Verbeuren, 1993, Evidence for induction of a non-endothelial NO synthase in aortas of cholesterol-fed rabbits, J Cardiovasc Pharmacol, 21, 841, 10.1097/00005344-199305000-00023
Joly, 1992, Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries, Circ Res, 71, 331, 10.1161/01.RES.71.2.331
Sobey, 1995, Evidence that expression of inducible nitric oxide synthase in response to endotoxin is augmented in atherosclerotic rabbits, Circ Res, 77, 536, 10.1161/01.RES.77.3.536
Koglin J, Glysing-Jensen T, Mudgett JS, Russel ME. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 1998;in press.
Rubanyi, 1994, Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology, Pharmacol Rev, 46, 325
Horio, 1991, Increased plasma immunoreactive endothelin-1 concentration in hypercholesterolemic rats, Atherosclerosis, 89, 239, 10.1016/0021-9150(91)90065-B
Bath, 1991, Serum platelet-derived growth factor and endothelin concentrations in human hypercholesterolemia, J Intern Med, 230, 313, 10.1111/j.1365-2796.1991.tb00450.x
Lerman, 1991, Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis, New Engl J Med, 325, 997, 10.1056/NEJM199110033251404
Lerman, 1995, Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans, Circulation, 92, 2426, 10.1161/01.CIR.92.9.2426
Boulanger, 1992, Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium, Circ Res, 70, 1191, 10.1161/01.RES.70.6.1191
Maemura, 1992, Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury, Gerontology, 38, 29, 10.1159/000213360
Chester, 1992, Effect of endothelin on normal and diseased human coronary arteries, Eur J Clin Invest, 22, 210, 10.1111/j.1365-2362.1992.tb01828.x
Tabuchi, 1989, Endothelin inhibits presynaptic adrenergic neurotransmission in rat mesenteric artery, Biochem Biophys Res Commun, 161, 803, 10.1016/0006-291X(89)92671-5
Yang, 1990, Threshold concentration of endothelin-1 potentiates contractions to norepinephrine and serotonin in human arteries: a new mechanism of vasospasm?, Circulation, 82, 188, 10.1161/01.CIR.82.1.188
Lopez, 1990, Vascular response to endothelin-1 in atherosclerotic primates, Arteriosclerosis, 10, 1113, 10.1161/01.ATV.10.6.1113
Yanagisawa, 1989, Molecular biology and biochemistry of the endothelins, Trends Pharmacol Sci, 10, 374, 10.1016/0165-6147(89)90011-4
Dohi, 1992, Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries, Hypertension, 19, 131, 10.1161/01.HYP.19.2.131
Achmad, 1992, Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers, Biochem Biophys Res Commun, 189, 994, 10.1016/0006-291X(92)92302-E
Cooke, 1997, Arginine: a new therapy for atherosclerosis, Circulation, 95, 311, 10.1161/01.CIR.95.2.311
Creager, 1992, l-Arginine improves endothelium-dependent relaxation in hypercholesterolemic humans, J Clin Invest, 90, 1248, 10.1172/JCI115987
Wang, 1994, Dietary arginine prevents atherogenesis in the coronary artery of the hypercholesterolemic rabbit, J Am Coll Cardiol, 23, 452, 10.1016/0735-1097(94)90433-2
Tsao, 1994, l-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits, Arterioscler Thromb, 14, 1529, 10.1161/01.ATV.14.10.1529
Aji, 1997, l-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice, Circulation, 95, 430, 10.1161/01.CIR.95.2.430
Schwarzbacher, 1997, Local intramural delivery of l-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty, Circulation, 95, 1863, 10.1161/01.CIR.95.7.1863
Fung, 1992, Biochemical mechanism of organic nitrate action, Am J Cardiol, 70, 4B, 10.1016/0002-9149(92)90588-P
Stamler, 1992, Biochemistry of nitric oxide and its redox-activated forms, Science, 258, 1898, 10.1126/science.1281928
Lam, 1988, Platelets, vasoconstriction, and nitroglycerin during arterial wall injury: A new antithrombotic role for an old drug, Circulation, 78, 712, 10.1161/01.CIR.78.3.712
Gryglewski, 1986, Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor, Nature, 320, 454, 10.1038/320454a0
Beckmann, 1994, Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry, Biol Chem Hoppe-Seyler, 375, 81, 10.1515/bchm3.1994.375.2.81
Cannan, 1995, Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor, Circulation, 92, 3312, 10.1161/01.CIR.92.11.3312
Lerman, 1995, Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans, Circulation, 92, 2426, 10.1161/01.CIR.92.9.2426
Khimenko, 1996, Blocked ET-A receptors prevent ischemia and reperfusion injury in rat lungs, J Appl Physiol, 80, 203, 10.1152/jappl.1996.80.1.203
Dagassan, 1994, Role of endothelin during reperfusion after ischemia in isolated perfused rat heart, J Cardiovasc Pharmacol, 24, 867, 10.1097/00005344-199424060-00003
Reynolds, 1991, Endothelin-stimulated arachidonic acid release in vascular smooth muscle cells, FASEB J, 5, A1066
Aramori, 1993, Subtype selectivity of a novel endothelin antagonist, FR 139317, for the two endothelin receptors in transfected Chinese hamster ovary cells, Mol Pharmacol, 43, 127
Sogabe, 1992, A novel endothelin receptor antagonist: studies with FR139317, J Vasc Res, 29, 201
Frei, 1988, Antioxidant defenses and lipid peroxidation in human blood plasma, Proc Natl Acad Sci USA, 85, 9748, 10.1073/pnas.85.24.9748
Steinbrecher, 1984, Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids, Proc Natl Acad Sci USA, 81, 3883, 10.1073/pnas.81.12.3883
Anderson, 1995, The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion, New Engl J Med, 332, 488, 10.1056/NEJM199502233320802
Parthasarathy, 1986, Probucol inhibits oxidative modification of low density lipoprotein, J Clin Invest, 77, 641, 10.1172/JCI112349
Libby, 1997, Restenosis revisited—New targets, new therapies, New Engl J Med, 337, 418, 10.1056/NEJM199708073370608
Tardif, 1997, Probucol and multivitamins in the prevention of restenosis after coronary angioplasty, New Engl J Med, 337, 365, 10.1056/NEJM199708073370601
Simon, 1990, Restoration of endothelium-dependent relaxation in atherosclerotic arteries by probucol, Circulation, 82, III
McNamara, 1993, l-Arginine inhibits balloon catheter-induced intimal hyperplasia, Biochem Biophys Res Commun, 193, 291, 10.1006/bbrc.1993.1622
Tarry, 1994, l-Arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty, Arterioscler Thromb, 14, 938, 10.1161/01.ATV.14.6.938
Cooke, 1992, Antiatherosclerotic effects of l-arginine in the hypercholesterolemic rabbits, J Clin Invest, 90, 1168, 10.1172/JCI115937
Böger, 1995, Supplementation of hypercholesterolemic rabbits with l-arginine reduces the vascular release of superoxide anion and restores NO production, Atherosclerosis, 117, 273, 10.1016/0021-9150(95)05582-H
Hecker, 1995, Characterization of the stable l-arginine-derived relaxing factor released from cytokine-stimulated vascular smooth muscle cells as an NG-hydroxyl-l-arginine-nitric oxide adduct, Proc Natl Acad Sci USA, 92, 4671, 10.1073/pnas.92.10.4671
Von der Leyen, 1995, Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene, Proc Natl Acad Sci USA, 92, 1137, 10.1073/pnas.92.4.1137
Morishita, 1994, Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides, J Clin Invest, 93, 1458, 10.1172/JCI117123
Morishita, 1995, A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo, Proc Natl Acad Sci USA, 92, 5855, 10.1073/pnas.92.13.5855
Picard, 1992, Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors, Proc Natl Acad Sci USA, 89, 6876, 10.1073/pnas.89.15.6876
Bucala, 1994, Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency, Proc Natl Acad Sci USA, 91, 9441, 10.1073/pnas.91.20.9441
Requena, 1992, Aminoguanidine inhibits the modification of proteins by lipid peroxidation derived aldehydes: a possible antiatherogenic agent, Diabetes Res, 20, 43
Tamai, 1997, Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans, Circulation, 95, 76, 10.1161/01.CIR.95.1.76
Aengevaeren, 1996, Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease, J Am Coll Cardiol, 28, 1696, 10.1016/S0735-1097(96)00388-9
Billingham, 1997, Graft coronary disease: old and new dimensions, Cardiovasc Pathol, 6, 95